Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737358 · ClinicalTrials.gov registry record · Phase 2
N-acetylcysteine for Tobacco Use Disorder
A Phase 2 study of Smoking and Nicotine Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 114
- Enrollment target
- 1
- Study location
NCT02737358: Completed Phase 2 study of Smoking and Nicotine Dependence, sponsored by Medical University of South Carolina.
NCT02737358 is a Phase 2 study of Smoking and Nicotine Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 114 participants, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02737358, a Phase 2 study of Smoking and Nicotine Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effects of administering N-Acetylcysteine (NAC) to assist in initial cessation and/or relapse prevention in adult cigarette smokers.
Primary Outcome
Abstinence will be measured through biochemical verification via breath carbon monoxide. Abstinence is defined as a 75% reduction in carbon monoxide values (parts per million) from smoking baseline levels.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG N-acetylcysteine (NAC)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2016-08-30 |
| Est. Completion | 2019-10-10 |
| Phase | Phase 2 |
What the finished NCT02737358 record still lists
NCT02737358 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02737358 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT02737358 about?
NCT02737358 is a clinical study titled "N-acetylcysteine for Tobacco Use Disorder". The purpose of this study is to assess the effects of administering N-Acetylcysteine (NAC) to assist in initial cessation and/or relapse prevention in adult cigarette smokers.
What is the current status of trial NCT02737358?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 114 participants. The study started on 2016-08-30. Estimated completion is 2019-10-10.
What conditions does trial NCT02737358 study?
This clinical trial studies the following conditions: Smoking, Nicotine Dependence.
What interventions are being tested in trial NCT02737358?
The interventions under investigation include: Placebo (OTHER), N-acetylcysteine (NAC) (DRUG).
Who is sponsoring clinical trial NCT02737358?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02737358 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02737358's enrollment target sits among peer trials
114 68th of 123 higher than 55 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
RECRUITING · Phase 2
-
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
RECRUITING · Phase 2
-
App for Reducing Cravings to Smoke
RECRUITING · Phase 2
-
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
ACTIVE NOT RECRUITING · Phase 2
-
Proactive Health Intervention for Tobacco Users (Get PHIT)
COMPLETED · Phase 2
-
Computer-Assisted Intervention for Smoking During Pregnancy
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI